Annie Moore, an internal medicine doctor who is board-certified in obesity medicine and has extensive experience prescribing GLP-1 weight loss medications to her patients
Individuals with obesity or elevated weight-related risk Patients managing insulin resistance, prediabetes, or type 2 diabetes often see added benefits due to improved blood sugar control
Your plan should reflect your biology, lifestyle, and goals
10.1177/0091270008323753 91 InzucchiS
Some studies indicate that short-term infliximab treatment (14 weeks) decreases both bone formation markers, such as osteocalcin, and bone resorption markers, such as N-terminal telopeptide (NTX) (87)
"Suntan could come 'in an implant'"